Greg Rossino is a seasoned professional in investor relations, currently serving as the Senior Director of Investor Relations at Viridian Therapeutics, Inc. Since 2025, Greg has continued to build on a robust foundation of experience in the biotech and pharmaceutical sectors, previously holding roles such as Director of Investor Relations at Moderna and Group Finance - Business Insights Director at AstraZeneca. With a Bachelor of Science in Economics from the Eller College of Management at The University of Arizona and an MBA from Boston College Carroll School of Management, Greg combines academic excellence with a wealth of practical expertise from companies like Alexion Pharmaceuticals and Raytheon.
Location
Boston, United States
This person is not in any teams
This person is not in any offices